期刊文献+

妊娠糖尿病患者妊娠期血清鸢尾素水平与巨大儿的相关性 被引量:2

Correlation Between the Serum Irisin Level and Giant Infant in Patients with Gestational Diabetes Mellitus
下载PDF
导出
摘要 目的分析妊娠糖尿病患者妊娠期血清鸢尾素水平与巨大儿的相关性。方法选取2018年7月至2020年11月河南省人民医院豫东分院收治的42例发生巨大儿的妊娠糖尿病患者作为巨大儿组,选取同期收治的42例未发生巨大儿的妊娠糖尿病患者作为非巨大儿组。所有患者入院时均接受血清鸢尾素检测,并使用超声仪测定胎儿双顶径、腹围及股骨长,测定患者空腹血糖、糖化血红蛋白水平。分析妊娠糖尿病患者妊娠期血清鸢尾素水平、空腹血糖、糖化血红蛋白与巨大儿的相关性;分析血清鸢尾素水平、空腹血糖、糖化血红蛋白对妊娠糖尿病患者发生巨大儿的影响;绘制受试者工作特征(ROC)曲线,分析血清鸢尾素水平、空腹血糖、糖化血红蛋白对妊娠糖尿病患者发生巨大儿的预测价值。结果巨大儿组血清鸢尾素水平低于非巨大儿组,空腹血糖、糖化血红蛋白、胎儿双顶径、腹围及股骨长高于非巨大儿组,差异有统计学意义(P<0.05)。双变量Pearson直线相关检验结果显示,妊娠糖尿病患者血清鸢尾素水平与患者空腹血糖、糖化血红蛋白水平、胎儿双顶径、腹围及股骨长呈负相关(r<0,P<0.05)。logistic回归分析结果显示,血清鸢尾素高是妊娠糖尿病患者发生巨大儿的保护因素(OR<1,P<0.05)、空腹血糖、糖化血红蛋白是妊娠糖尿病患者发生巨大儿的危险因素(OR>1,P<0.05)。绘制ROC曲线,结果显示血清鸢尾素、空腹血糖、糖化血红蛋白预测妊娠糖尿病患者发生巨大儿的曲线下面积(AUC)>0.7,具有较高的价值。结论妊娠糖尿病患者妊娠期血清鸢尾素水平与巨大儿密切相关,且可预测巨大儿的发生风险。 Objective To analyze the correlation between the serum irisin level and giant infant in patients with gestational diabetes mellitus.Methods The clinical data of 42 patients with gestational diabetes mellitus who had giant infants in Yudong Branch of Henan Provincial People’s Hospital from July 2018 to November 2020 were analyzed retrospectively,and included in the giant infant group.A total of 42 patients with gestational diabetes mellitus who did not have giant infant were selected at the same time,and were included in the non-giant group.All patients were tested for serum irisin at admission,the fetal diameter,abdominal circumference and femur length were measured by ultrasonic instrument,the fasting blood glucose and glycosylated hemoglobin levels of patients were measured.The correlation between serum irisin,fasting blood glucose,glycosylated hemoglobin and giant infant in patients with gestational diabetes mellitus was analyzed.The influence of serum irisin level,fasting blood glucose and glycosylated hemoglobin on the occurrence of giant infant in patients with gestational diabetes mellitus were analyzed.Receiver operating characteristic(ROC)curve was drawn,and the predictive value of serum iridoin level,fasting blood glucose and glycosylated hemoglobin on the occurrence of giant infants in patients with gestational diabetes mellitus were analyzed.Results The serum irisin level of patients in the giant infant group was lower than that of the non-giant infant group,and the fasting blood glucose,glycosylated hemoglobin,fetal double apex diameter,abdominal circumference and femur length were higher than those in the non-giant infant group(P<0.05).Through bivariate Pearson linear correlation test,the results showed that the serum iridoin level in gestational diabetes mellitus was negatively correlated with fasting blood glucose,glycosylated hemoglobin level,fetal double apex diameter,abdominal circumference and femur length(r<0,P<0.05).The results of logistic regression analysis showed that high serum irisin was a protective factor for giant infants(OR<1,P<0.05),and fasting blood glucose and glycosylated hemoglobin were risk factors for giant infants(OR>1,P<0.05)in patients with gestational diabetes.The ROC curve showed that the area under curve(AUC)of serum i irisin level,fasting blood glucose and glycosylated hemoglobin in predicting the giant infant in patients with gestational diabetes mellitus were>0.7,which had higher value.Conclusion The serum irisin level in patients with gestational diabetes mellitus is closely related to the giant infant,and it can predict the risk of giant infant.
作者 吴秋霜 WU Qiushuang(First Ward,Department of Obstetrics and Gynecology,Yudong Branch of Henan Provincial People’s Hospital/Minquan County People’s Hospital,Shangqiu 476800,China)
出处 《河南医学研究》 CAS 2021年第29期5460-5463,共4页 Henan Medical Research
关键词 妊娠糖尿病 血清鸢尾素 巨大儿 相关性 gestational diabetes mellitus serum irisin giant infant correlation
  • 相关文献

参考文献8

二级参考文献79

  • 1Kahn CR.Joslin糖尿病学[M].14版.潘长玉,主译.北京:人民卫生出版社,2005:550-552.
  • 2中华医学会妇产科学分会产科学组,中华医学会围产医学分会妊娠合并糖尿病协作组.妊娠合并糖尿病临床诊断与治疗推荐指南(草案)[J].中华妇产科杂志,2007,42:426-428.
  • 3中华人民共和国国家卫生部.WS331-2011妊娠期糖尿病诊断[s]北京:中华人民共和国国家卫生部,2011.
  • 4International Association of Diabetes and Pregnancy 3tudy Groups Consensus Panel,Metzger BE,Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J].Diabetes Care,2010,33:676-682.
  • 5International Diabetes Federation. Global Guideline on Pregnancy and Diabetes[S].Brussels: International Diabetes Federation,2009.
  • 6Walker JD. Diabetes in pregnancy:management of diabetes and its complications from pre-conception to the postnatal period. NICE guideline 63. London, March 2008[J]. Diabet Med, 2008, 25: 1025-1027.
  • 7Hoffman L,Nolan C,Wilson JD,et al.Gestational diabetes mellitus-management guidellnes.The Australasian Diabetes in Pregnancy Society[J].Med J Aust, 1998,169:93-97.
  • 8Canadian Diabetes Association.2008 CDA clinical practiceguidelines for the prevention and management of diabetes in Canada[J].Can J Diabetes,2008,32:S168-180.
  • 9Hadar E,Oats J,Hod M.Towards new diagnostic criteria for diagnosing GDM:the HAPO study[J].J Perinat Med, 2009, 37: 447-449.
  • 10Crowther CA,Hiller JE,Moss JR,et al.Effeet of treatment of gestational diabetes mellitus on pregnancy outeomes[J].N Engl J Med,2005,352:2477-2486.

共引文献1505

同被引文献17

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部